While some studies have revealed that TGF-β, ERK1/2, and NF-κB signaling pathways are linked to the regulation of GC metastasis [2–4], the molecular mechanisms underlying GC recurrence and metastasis remain poorly understood. Here, NFKB1 is linked to gastric cancer.